Episode 212: Dr. Marty Lerner

Today, we are thrilled to have Dr. Marty Lerner return to the podcast. Dr. Lerner is the Executive Director of the Milestones in Recovery Eating Disorders Program and a licensed, board-certified clinical psychologist. He has been a pioneering voice in understanding the complex overlap between eating disorders, food addiction, and the emerging use of GLP-1 receptor agonists. His insights have been featured in professional journals, major newspapers like USA Today and The Wall Street Journal, and national television programs including 20/20, NPR Report, and Nightline. He is also the author of A Guide to Eating Disorder Recovery, available as a free eBook on the Milestones program website.

In this episode, Dr. Lerner shares his expert perspective on the evolving conversation around eating disorders, food addiction, and the growing use of GLP-1 medications. We explore their mechanisms, clinical implications, and the ethical considerations surrounding their use in treatment.

What We Cover in This Episode:

State of the Field: Changes in the Last Three Years

• How has the intersection of eating disorders and food addiction evolved?

• Has there been more collaboration between these fields?

 

GLP-1 Receptor Agonists: A Game-Changer or a Concern?

• Dr. Lerner's initial reaction to GLP-1s and whether his perspective has shifted.

• Understanding their mechanisms: insulin sensitivity, delayed gastric emptying, weight loss, and craving reduction.

 

How GLP-1s Impact Cravings and Satiety

• How do GLP-1 receptor agonists manage cravings and reduce binge-eating behaviors?

• How do they influence hunger and satiety signals in the brain?

 

Clinical Insights and Considerations

• What major changes has Dr. Lerner witnessed in his clients using GLP-1s?

• Who benefits most from these medications? Who should avoid them?

• Are GLP-1s safe for individuals with eating disorders?

• Can they be used safely for food addiction?

• Are there contraindications for individuals with underlying mental health conditions like anxiety and depression?

• Do these medications address emotional/psychological components of food addiction?

 

Potential Side Effects and Long-Term Considerations

• What are the most concerning side effects?

• How do they affect thyroid function, sex hormones, and overall hormonal balance?

• Is there evidence of metabolic downregulation or tolerance with prolonged use?

• How has the widespread use of these medications changed Dr. Lerner’s therapeutic practice?

 

Advice for Clinicians and Patients

• What should clinicians consider when prescribing or recommending GLP-1s?

• What should patients know before deciding to use them?

 

Looking Ahead: Hopes and Concerns

• What are Dr. Lerner’s hopes for the future of GLP-1s in treatment?

• What concerns does he have about their long-term impact?

• His ongoing work and research in the field.

• His advice to his younger self about GLP-1 medications.

 

Thank You for Listening! We’re grateful to have you on this journey. Remember: Recovery is about progress, perseverance, and connection. You’ve got this! 💪

The content of our show is educational only. It does not supplement or supersede your healthcare provider's professional relationship and direction. Always seek the advice of your physician or other qualified mental health providers with any questions you may have regarding a medical condition, substance use disorder, or mental health concern.

 

Previous
Previous

Episode 213: Michael Prager

Next
Next

Episode 211: Dr. Amelia Scott Barrett